Vestibular Schwannoma
Oncology·MeSH: Neuroma, Acoustic
Prevalence
5.0 / 100K
1 drug in development·1 company·4 clinical trials
Drug Pipeline by Phase
Preclinical(1)
| Drug | Company |
|---|---|
| ak-antivegf | Akouos, Inc. (AKUS) |
Frequently asked questions
How many drugs are in development for Vestibular Schwannoma?
BioSniper tracks 1 drug in development for Vestibular Schwannoma across 1 company.
How many clinical trials target Vestibular Schwannoma?
There are 4 clinical trials targeting Vestibular Schwannoma tracked by BioSniper.
What is the prevalence of Vestibular Schwannoma?
The estimated prevalence of Vestibular Schwannoma is approximately 5.0 per 100,000 population.
Deep-dive into Vestibular Schwannoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis